We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.89B
AUM Growth
+$125M
Cap. Flow
-$226M
Cap. Flow %
-5.82%
Top 10 Hldgs %
15.92%
Holding
230
New
17
Increased
95
Reduced
68
Closed
21

Top Buys

Rank Stock Value
1
ATMI
A T M I INC
ATMI
+$32.5M
2
DECK icon
Deckers Outdoor
DECK
+$29.6M
3
EXAS
Exact Sciences
EXAS
+$24.2M
4
EAT icon
Brinker International
EAT
+$21.4M
5
GIMO
Gigamon Inc.
GIMO
+$19.6M

Top Sells

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$40.1M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$39M
3
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$37.5M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$31.6M
5
BID
Sotheby's
BID
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 25.66%
2 Consumer Discretionary 15.66%
3 Healthcare 15.51%
4 Industrials 11.08%
5 Communication Services 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUSHA icon
201
Rush Enterprises Class A
RUSHA
$6.22B
$1.43M 0.04%
108,540
+37,980
+54% +$480K
WIRE
202
DELISTED
Encore Wire Corp
WIRE
$1.21M 0.03%
22,367
+7,837
+54% +$370K
SAUC
203
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$1.19M 0.03%
249,586
+32,656
+15% +$199K
FLNA
204
Filana Therapeutics
FLNA
$48.1M
$1.06M 0.03%
31,283
+10,966
+54% +$291K
CTG
205
DELISTED
Computer Task Group, Inc.
CTG
$1.02M 0.03%
54,320
+18,990
+54% +$340K
PRTA icon
206
Prothena Corp
PRTA
$450M
$899K 0.02%
33,894
– –
AVEO
207
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$869K 0.02%
47,465
– –
JRCC
208
DELISTED
JAMES RIVER COAL NEW
JRCC
$752K 0.02%
557,400
– –
SGEN
209
DELISTED
Seagen Inc. Common Stock
SGEN
$371K 0.01%
9,300
-362,550
-97% -$14.8M
ALGN icon
210
Align Technology
ALGN
$12.3B
– –
-455,400
Closed -$21.9M
ANGI icon
211
Angi Inc
ANGI
$196M
– –
-101,017
Closed -$22.7M
BMRN icon
212
BioMarin Pharmaceuticals
BMRN
$12.4B
– –
-556,200
Closed -$40.1M
EW icon
213
Edwards Lifesciences
EW
$51.7B
– –
-1,071,000
Closed -$12.4M
HBI
214
DELISTED
Hanesbrands
HBI
– –
-1,048,400
Closed -$16.3M
IONS icon
215
Ionis Pharmaceuticals
IONS
$9.4B
– –
-842,689
Closed -$31.6M
MTZ icon
216
MasTec
MTZ
$21.9B
– –
-261,378
Closed -$7.92M
OII icon
217
Oceaneering
OII
$4.77B
– –
-27,700
Closed -$2.25M
REGN icon
218
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-124,800
Closed -$39M
UHS icon
219
Universal Health Services
UHS
$10.5B
– –
-238,600
Closed -$17.9M
CHS
220
DELISTED
Chicos FAS, Inc.
CHS
– –
-889,900
Closed -$14.8M
TIF
221
DELISTED
Tiffany & Co.
TIF
– –
-148,900
Closed -$11.4M
TIVO
222
DELISTED
Tivo Inc
TIVO
– –
-627,300
Closed -$12M
CARB
223
DELISTED
Carbonite Inc
CARB
– –
-110,069
Closed -$1.65M
SFLY
224
DELISTED
Shutterfly, Inc.
SFLY
– –
-441,854
Closed -$24.7M
TNGO
225
DELISTED
Tangoe, Inc.
TNGO
– –
-529,219
Closed -$12.6M
6 7 8
9
10

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Granahan Investment Management held 230 positions worth $3.89B, up 3.3% from $3.76B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management withdrew a net $226M in Q4 2013, closing 21 positions and reducing 68 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $40.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Granahan Investment Management opened a new position in Deckers Outdoor worth $33.8M.

  • Granahan Investment Management's largest Q4 2013 buy was Deckers Outdoor: 2,399,400 shares worth $33.8M.
  • Granahan Investment Management added most to A T M I INC in Q4 2013, an estimated $32.5M increase.
  • Granahan Investment Management's biggest Q4 2013 reduction was Sotheby's, cutting an estimated $27.7M.
  • Granahan Investment Management fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $40.1M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $3.89B portfolio in Q4 2013.
  • Granahan Investment Management opened 17 new positions and closed 21 in Q4 2013.
  • Granahan Investment Management's portfolio value rose 3.3% quarter-over-quarter to $3.89B.

Based on Granahan Investment Management's 13F filing for Q4 2013, filed 30 Jan 2014.